title: The European League Against Rheumatism (EULAR) - 17th Annual European Congress of Rheumatology (June 8-11, 2016 - London, UK).
abstract: The 2016 Annual European Congress of Rheumatology, an annual conference organized by the European League Against Rheumatism (EULAR), took place in London, U.K. Over 4,000 abstracts were submitted this year with over 199 sessions and poster tours on offer. The congress has become a major event in the field of rheumatology with participants attending from around the world. The oral sessions, poster displays and lectures cover a broad spectrum of topics, including the latest understanding of disease processes, as well as recent advances in diagnosis and patient care.
authors.affiliation: Thomson Reuters, London, U.K. glenda.walker@thomsonreuters.com.
authors.forename: G
authors.initials: G
authors.lastname: Walker
authors.affiliation: Thomson Reuters, London, U.K.
authors.forename: G
authors.initials: G
authors.lastname: Croasdell
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D006801:Humans; D010880:Piperidines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012219:Rheumatology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D010880:Piperidines; D011743:Pyrimidines; D011758:Pyrroles; C540932:milatuzumab; C541220:canakinumab; C568922:sirukumab; C479163:tofacitinib
keywords: Canakinumab; GP-2013; GS-5745; GS-9876; Golimumab; MGD-010; Milatuzumab; PF-06651600; PRX-003; Sirukumab; Tofacitinib